Universität Wien

230147 SE Political and cultural economics of Pharmaceuticals (2015S)

5.00 ECTS (2.00 SWS), SPL 23 - Soziologie
Continuous assessment of course work

Registration/Deregistration

Note: The time of your registration within the registration period has no effect on the allocation of places (no first come, first served).

Details

max. 25 participants
Language: English

Lecturers

Classes (iCal) - next class is marked with N

Monday 04.05. 09:15 - 11:45 Seminarraum STS, NIG Universitätsstraße 7/Stg. II/6. Stock, 1010 Wien
Tuesday 05.05. 09:15 - 11:45 Seminarraum STS, NIG Universitätsstraße 7/Stg. II/6. Stock, 1010 Wien
Wednesday 06.05. 09:15 - 11:45 Seminarraum STS, NIG Universitätsstraße 7/Stg. II/6. Stock, 1010 Wien
Thursday 07.05. 09:15 - 11:45 Seminarraum STS, NIG Universitätsstraße 7/Stg. II/6. Stock, 1010 Wien
Monday 11.05. 09:15 - 11:45 Seminarraum STS, NIG Universitätsstraße 7/Stg. II/6. Stock, 1010 Wien
Tuesday 12.05. 09:30 - 12:00 Seminarraum STS, NIG Universitätsstraße 7/Stg. II/6. Stock, 1010 Wien
Wednesday 13.05. 10:00 - 11:30 Seminarraum STS, NIG Universitätsstraße 7/Stg. II/6. Stock, 1010 Wien
Tuesday 19.05. 09:00 - 13:30 Seminarraum STS, NIG Universitätsstraße 7/Stg. II/6. Stock, 1010 Wien

Information

Aims, contents and method of the course

In recent years, Science and Technology Studies has learned that pharmaceuticals represent a fascinating topic: pharmaceuticals connect science and medicine with cultures and markets, and with regulators, corporations and a broad range of other actors. In this course we will have a number of thematic foci: (1) the use of the pharmaceutical as 'sampling device' to open up and study broader social phenomena, (2) situating the pharmaceutical as an object at the boundaries of the licit and illicit, enhancement and treatment, and normal and pathological (3) interpreting pharmaceutical consumption as a cultural text and a site of identity politics (4) charting the movements of pharmaceuticals as global commodities with heterogeneous maps of access, cost, risk and benefit, (5) understanding the pharmaceutical as a site of knowledge production, through organized clinical trials and through the more inchoate experience with drug risks in the general population, (6) analyzing the creation and maintenance of markets for drugs and knowledge about them, and (7) examining the politics and economies involved in regulating pharmaceutical markets on local and global scales.

Assessment and permitted materials

Minimum requirements and assessment criteria

Examination topics

Reading list


Association in the course directory

Last modified: Mo 07.09.2020 15:39